Ikeda H - Search Results

1

[Human NK inhibitory and activating receptors that bind to human leukocyte antigens (HLA) regulate NK cells and T cells].

Ikeda H, Coulie PG. Ikeda H, et al. Tanpakushitsu Kakusan Koso. 1997 Nov;42(15):2510-21. Tanpakushitsu Kakusan Koso. 1997. PMID: 9391340 Review. Japanese. No abstract available.

2

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor.

Ikeda H, Lethé B, Lehmann F, van Baren N, Baurain JF, de Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG. Ikeda H, et al. Immunity. 1997 Feb;6(2):199-208. doi: 10.1016/s1074-7613(00)80426-4. Immunity. 1997. PMID: 9047241 Free article.

3

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.

Lehmann F, Marchand M, Hainaut P, Pouillart P, Sastre X, Ikeda H, Boon T, Coulie PG. Lehmann F, et al. Among authors: ikeda h. Eur J Immunol. 1995 Feb;25(2):340-7. doi: 10.1002/eji.1830250206. Eur J Immunol. 1995. PMID: 7875194

4

PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells.

van Baren N, Chambost H, Ferrant A, Michaux L, Ikeda H, Millard I, Olive D, Boon T, Coulie PG. van Baren N, et al. Among authors: ikeda h. Br J Haematol. 1998 Sep;102(5):1376-9. doi: 10.1046/j.1365-2141.1998.00982.x. Br J Haematol. 1998. PMID: 9753074 Free article.

5

Antitumor immunity at work in a melanoma patient.

Coulie PG, Ikeda H, Baurain JF, Chiari R. Coulie PG, et al. Among authors: ikeda h. Adv Cancer Res. 1999;76:213-42. doi: 10.1016/s0065-230x(08)60778-2. Adv Cancer Res. 1999. PMID: 10218103 Review.

6

Immune evasion through mitochondrial transfer in the tumour microenvironment.

Ikeda H, Kawase K, Nishi T, Watanabe T, Takenaga K, Inozume T, Ishino T, Aki S, Lin J, Kawashima S, Nagasaki J, Ueda Y, Suzuki S, Makinoshima H, Itami M, Nakamura Y, Tatsumi Y, Suenaga Y, Morinaga T, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Nakamura Y, Kiniwa Y, Ichihara E, Hayashi H, Ikeda JI, Hanazawa T, Toyooka S, Mano H, Suzuki T, Osawa T, Kawazu M, Togashi Y. Ikeda H, et al. Nature. 2025 Jan 22. doi: 10.1038/s41586-024-08439-0. Online ahead of print. Nature. 2025. PMID: 39843734

7

Impact of meropenem exposure on fluoroquinolone and carbapenem resistance in Pseudomonas aeruginosa infection in inpatients in a Japanese university hospital: Insights into oprD mutations and efflux pump overexpression.

Yamochi T, Ugajin K, On R, Inoue S, Ikeda H, Yamochi T, Takimoto M, Tokimatsu I. Yamochi T, et al. Among authors: ikeda h. J Glob Antimicrob Resist. 2025 Jan 14:S2213-7165(25)00004-9. doi: 10.1016/j.jgar.2024.12.029. Online ahead of print. J Glob Antimicrob Resist. 2025. PMID: 39818330 Free article.

8

Internal carotid artery dissection leading to occlusion in a patient with nonelongated styloid process: illustrative case.

Osuki T, Ikeda H, Uezato M, Fujiwara T, Hata H, Kinosada M, Kurosaki Y, Chin M. Osuki T, et al. Among authors: ikeda h. J Neurosurg Case Lessons. 2025 Jan 13;9(2):CASE24719. doi: 10.3171/CASE24719. Print 2025 Jan 13. J Neurosurg Case Lessons. 2025. PMID: 39805105 Free PMC article.

9

Cancer immunotherapy in progress-an overview of the past 130 years.

Ikeda H. Ikeda H. Int Immunol. 2025 Jan 10:dxaf002. doi: 10.1093/intimm/dxaf002. Online ahead of print. Int Immunol. 2025. PMID: 39792088

10

Minimum Scaling Model and Exact Exponents for the Nambu-Goldstone Modes in the Vicsek Model.

Ikeda H. Ikeda H. Phys Rev Lett. 2024 Dec 20;133(25):258301. doi: 10.1103/PhysRevLett.133.258301. Phys Rev Lett. 2024. PMID: 39752672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,522 results

Search Page

Filters